Immunological functions of the neuropilins and plexins as receptors for semaphorins

Nature Reviews Immunology

Volumn 13, Issue 11, 2013, Pages 802-814

  Kumanogoh, Atsushi ^a,b   Kikutani, Hitoshi ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPILIN; PLEXIN; RECEPTOR PROTEIN; SEMAPHORIN;

CELL TYPE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOPHILINS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SEMAPHORINS; SIGNAL TRANSDUCTION;

EID: 84886804716     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3545     Document Type: Review

References (129)

1. Kolodkin, A. L., Matthes, D. J. & Goodman, C. S. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75, 1389-1399 (1993).
2. Semaphorin Nomenclature Committee. Unified nomenclature for the semaphorins/collapsins. Cell 97, 551-552 (1999).
3. Pasterkamp, R. J. Getting neural circuits into shape with semaphorins. Nature Rev. Neurosci. 13, 605-618 (2012).
4. Takamatsu, H. & Kumanogoh, A. Diverse roles for semaphorin-plexin signaling in the immune system. Trends Immunol. 33, 127-135 (2012).
5. Tamagnone, L. Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer. Cancer Cell 22, 145-152 (2012).
6. Bruder, D. et al. Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 34, 623-630 (2004). (Pubitemid 39255909)
7. + regulatory T cells impairs mouse melanoma growth. J. Exp. Med. 209, 2001-2016 (2012).
8. + T reg cells. J. Exp. Med. 209, 1723-1742 (2012).
9. Yadav, M. et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713-1722 (2012).
10. Negishi-Koga, T. et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nature Med. 17, 1473-1480 (2011).
11. Hayashi, M. et al. Osteoprotection by semaphorin 3A. Nature 485, 69-74 (2012).
12. Toyofuku, T. et al. Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nature Cell Biol. 6, 1204-1211 (2004). (Pubitemid 39625119)
13. Gu, C. et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307, 265-268 (2005). (Pubitemid 40116243)
14. Casazza, A. et al. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J. Clin. Invest. 120, 2684-2698 (2010).
15. Maione, F. et al. Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. J. Clin. Invest. 122, 1832-1848 (2012).
16. Maione, F. et al. Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J. Clin. Invest. 119, 3356-3372 (2009).
17. Takegahara, N. et al. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nature Cell Biol. 8, 615-622 (2006). (Pubitemid 43827355)
18. Toyofuku, T. et al. Endosomal sorting by semaphorin 4A in retinal pigment epithelium supports photoreceptor survival. Genes Dev. 26, 816-829 (2012).
19. Bougeret, C. et al. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J. Immunol. 148, 318-323 (1992).
20. Kumanogoh, A. et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 13, 621-631 (2000).
21. Shi, W. et al. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 13, 633-642 (2000).
22. Kumanogoh, A. et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419, 629-633 (2002).
23. Kumanogoh, A. et al. Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice. Immunity 22, 305-316 (2005). (Pubitemid 40387473)
24. Suzuki, K. et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through α1β1 integrin. Nature 446, 680-684 (2007). (Pubitemid 46606878)
25. Takamatsu, H. et al. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nature Immunol. 11, 594-600 (2010)
26. Suzuki, K., Kumanogoh, A. & Kikutani, H. Semaphorins and their receptors in immune cell interactions. Nature Immunol. 9, 17-23 (2008). (Pubitemid 350286199)
27. Capparuccia, L. & Tamagnone, L. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment-two sides of a coin. J. Cell Sci. 122, 1723-1736 (2009).
28. Nojima, S. et al. A point mutation in Semaphorin 4A associates with defective endosomal sorting and causes retinal degeneration. Nature Commun. 4, 1406 (2013).
29. Okuno, T., Nakatsuji, Y. & Kumanogoh, A. The role of immune semaphorins in multiple sclerosis. FEBS Lett. 585, 3829-3835 (2011).
30. Takagi, S. et al. The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors. Neuron 7, 295-307 (1991).
31. He, Z. & Tessier-Lavigne, M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90, 739-751 (1997). (Pubitemid 27357965)
32. Kolodkin, A. L. et al. Neuropilin is a semaphorin III receptor. Cell 90, 753-762 (1997). (Pubitemid 27357966)
33. Takahashi, T. et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 99, 59-69 (1999). (Pubitemid 29468630)
34. Tamagnone, L. et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 71-80 (1999). (Pubitemid 29468631)
35. Prud'homme, G. J. & Glinka, Y. Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity. Oncotarget 3, 921-939 (2012).
36. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745 (1998). (Pubitemid 28155313)
37. Glinka, Y. & Prud'homme, G. J. Neuropilin-1 is a receptor for transforming growth factor β1, activates its latent form, and promotes regulatory T cell activity. J. Leukoc. Biol. 84, 302-310 (2008). (Pubitemid 351960305)
38. Robinson, S. D. et al. αvβ3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis. J. Biol. Chem. 284, 33966-33981 (2009).
39. Valdembri, D. et al. Neuropilin-1/GIPC1 signaling regulates α5β1 integrin traffic and function in endothelial cells. PLoS Biol. 7, e25 (2009).
40. Lanahan, A. et al. The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis. Dev. Cell 25, 156-168 (2013).
41. Dzionek, A. et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165, 6037-6046 (2000).
42. Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L. & Sisirak, V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29, 163-183 (2011).
43. Grage-Griebenow, E. et al. Anti-BDCA-4 (neuropilin-1) antibody can suppress virus-induced IFN-α production of plasmacytoid dendritic cells. Immunol. Cell Biol. 85, 383-390 (2007). (Pubitemid 47035609)
44. Lepelletier, Y. et al. Control of human thymocyte migration by neuropilin-1/semaphorin-3A-mediated interactions. Proc. Natl Acad. Sci. USA 104, 5545-5550 (2007). (Pubitemid 47175717)
45. Tordjman, R. et al. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nature Immunol. 3, 477-482 (2002). (Pubitemid 34520798)
46. Sarris, M., Andersen, K. G., Randow, F., Mayr, L. & Betz, A. G. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28, 402-413 (2008).
47. Solomon, B. D., Mueller, C., Chae, W. J., Alabanza, L. M. & Bynoe, M. S. Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 108, 2040-2045 (2011).
48. Battaglia, A. et al. Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Immunology 123, 129-138 (2008). (Pubitemid 350256004)
49. Delgoffe, G. M. et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 501, 252-256 (2013).
50. Serini, G. et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424, 391-397 (2003). (Pubitemid 36917481)
51. Makino, N. et al. Involvement of Sema4A in the progression of experimental autoimmune myocarditis. FEBS Lett. 582, 3935-3940 (2008).
52. Oinuma, I., Ishikawa, Y., Katoh, H. & Negishi, M. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305, 862-865 (2004). (Pubitemid 39038420)
53. Tamagnone, L. & Mazzone, M. Semaphorin signals on the road of endothelial tip cells. Dev. Cell 21, 189-190 (2011).
54. Barberis, D. et al. p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling. J. Cell Sci. 118, 4689-4700 (2005). (Pubitemid 41646379)
55. Perrot, V., Vazquez-Prado, J. & Gutkind, J. S. Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. J. Biol. Chem. 277, 43115-43120 (2002). (Pubitemid 35285695)
56. Swiercz, J. M., Kuner, R., Behrens, J. & Offermanns, S. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 35, 51-63 (2002). (Pubitemid 34804322)
57. Terman, J. R., Mao, T., Pasterkamp, R. J., Yu, H. H. & Kolodkin, A. L. MICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsion. Cell 109, 887-900 (2002). (Pubitemid 34786003)
58. Toyofuku, T. et al. FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nature Neurosci. 8, 1712-1719 (2005). (Pubitemid 41683199)
59. Takegahara, N. et al. Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements. FASEB J. 24, 4782-4792 (2010).
60. Saito, Y., Oinuma, I., Fujimoto, S. & Negishi, M. Plexin-B1 is a GTPase activating protein for M-Ras, remodelling dendrite morphology. EMBO Rep. 10, 614-621 (2009).
61. Wang, Y. et al. Plexins are GTPase-activating proteins for Rap and are activated by induced dimerization. Sci. Signal. 5, ra6 (2012).
62. Giordano, S. et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nature Cell Biol. 4, 720-724 (2002). (Pubitemid 34993710)
63. Toyofuku, T. et al. Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev. 18, 435-447 (2004). (Pubitemid 38316350)
64. Wong, A. W. et al. CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions. Nature Immunol. 4, 891-898 (2003). (Pubitemid 37098660)
65. Gu, C. & Giraudo, E. The role of semaphorins and their receptors in vascular development and cancer. Exp. Cell Res. 319, 1306-1316 (2013).
66. Suto, F. et al. Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers. Neuron 53, 535-547 (2007). (Pubitemid 46216759)
67. Kigel, B., Rabinowicz, N., Varshavsky, A., Kessler, O. & Neufeld, G. Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. Blood 118, 4285-4296 (2011).
68. Roney, K., Holl, E. & Ting, J. Immune plexins and semaphorins: old proteins, new immune functions. Protein Cell 4, 17-26 (2013).
69. Yamamoto, M. et al. Plexin-A4 negatively regulates T lymphocyte responses. Int. Immunol. 20, 413-420 (2008). (Pubitemid 351321249)
70. Wen, H., Lei, Y., Eun, S. Y. & Ting, J. P. Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor-and sepsis-induced cytokine storm. J. Exp. Med. 207, 2943-2957 (2010).
71. Tamagnone, L. & Comoglio, P. M. Signalling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol. 10, 377-383 (2000). (Pubitemid 30612470)
72. Deng, S. et al. Plexin-B2, but not Plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo. J. Neurosci. 27, 6333-6347 (2007). (Pubitemid 46890021)
73. Artigiani, S. et al. Functional regulation of semaphorin receptors by proprotein convertases. J. Biol. Chem. 278, 10094-10101 (2003). (Pubitemid 36800266)
74. Chabbert-de Ponnat, I. et al. Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively. Int. Immunol. 17, 439-447 (2005).
75. + B lymphocytes. Blood 101, 1962-1969 (2003). (Pubitemid 36237600)
76. Smith, E. P. et al. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. BMC Immunol. 12, 30 (2011).
77. Li, M. et al. Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis. Immunology 128, 114-122 (2009).
78. Giraudon, P. et al. Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells. J. Immunol. 172, 1246-1255 (2004). (Pubitemid 38113788)
79. Okuno, T. et al. Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 184, 1499-1506 (2010).
80. Oinuma, I., Katoh, H., Harada, A. & Negishi, M. Direct interaction of Rnd1 with Plexin-B1 regulates PDZ-RhoGEF-mediated Rho activation by Plexin-B1 and induces cell contraction in COS-7 cells. J. Biol. Chem. 278, 25671-25677 (2003). (Pubitemid 36835322)
81. Basile, J. R., Barac, A., Zhu, T., Guan, K. L. & Gutkind, J. S. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res. 64, 5212-5224 (2004). (Pubitemid 39006540)
82. Vikis, H. G., Li, W. & Guan, K. L. The plexin-B1/Rac interaction inhibits PAK activation and enhances Sema4D ligand binding. Genes Dev. 16, 836-845 (2002). (Pubitemid 34280107)
83. Holl, E. K. et al. Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production. PLoS ONE 7, e43333 (2012).
84. Witherden, D. A. et al. The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal yS T cell function. Immunity 37, 314-325 (2012).
85. Pasterkamp, R. J., Peschon, J. J., Spriggs, M. K. & Kolodkin, A. L. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 424, 398-405 (2003). (Pubitemid 36917482)
86. Kang, S. et al. Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via av(31 integrin. J. Immunol. 188, 1108-1116 (2012).
87. Comeau, M. R. et al. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 8, 473-482 (1998). (Pubitemid 28196801)
88. Kang, H. R., Lee, C. G., Homer, R. J. & Elias, J. A. Semaphorin 7A plays a critical role in TGF-(31-induced pulmonary fibrosis. J. Exp. Med. 204, 1083-1093 (2007). (Pubitemid 46798152)
89. Gitler, A. D., Lu, M. M. & Epstein, J. A. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev. Cell 7, 107-116 (2004). (Pubitemid 39172692)
90. Toyofuku, T. et al. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J. 26, 1373-1384 (2007). (Pubitemid 46398711)
91. Choi, Y. I. et al. PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla. Immunity 29, 888-898 (2008).
92. Holl, E. K. et al. Plexin-D1 is a novel regulator of germinal centers and humoral immune responses. J. Immunol. 186, 5603-5611 (2011).
93. Meda, C. et al. Semaphorin 4A exerts a proangiogenic effect by enhancing vascular endothelial growth factor-A expression in macrophages. J. Immunol. 188, 4081-4092 (2012).
94. Goshima, Y, Sasaki, Y., Yamashita, N. & Nakamura, F. Class 3 semaphorins as a therapeutic target. Expert Opin. Ther. Targets 16, 933-944 (2012).
95. Kumanogoh, A. et al. Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells. J. Immunol. 169, 1175-1181 (2002). (Pubitemid 34809157)
96. Nakatsuji, Y et al. Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-(3 therapy in multiple sclerosis. J. Immunol. 188, 4858-4865 (2012).
97. Ikeda, M., Hosoda, Y, Hirose, S., Okada, Y & Ikeda, E. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. J. Pathol. 191, 426-433 (2000). (Pubitemid 30649912)
98. Kong, J. S. et al. Anti-neuropilin-1 peptide inhibition of synoviocyte survival, angiogenesis, and experimental arthritis. Arthritis Rheum. 62, 179-190 (2010).
99. Catalano, A. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis. J. Immunol. 185, 6373-6383 (2010).
100. Vadasz, Z. et al. Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus. Arthritis Res. Ther. 14, R146 (2012).
101. Vadasz, Z. & Toubi, E. Semaphorin 3A-a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus. Lupus 21, 1266-1270 (2012).
102. Yamaguchi, J. et al. Semaphorin3A alleviates skin lesions and scratching behavior in NC/Nga mice, an atopic dermatitis model. J. Invest. Dermatol. 128, 2842-2849 (2008).
103. Kou, K. et al. Decreased expression of semaphorin-3A, a neurite-collapsing factor, is associated with itch in psoriatic skin. Acta Derm. Venereol 92, 521-528 (2012).
104. Sawaki, H. et al. Intranasal administration of semaphorin-3A alleviates sneezing and nasal rubbing in a murine model of allergic rhinitis. J. Pharmacol. Sci. 117, 34-44 (2011).
105. Nkyimbeng-Takwi, E. H. et al. Neuroimmune semaphorin 4A downregulates the severity of allergic response. Mucosal Immunol. 5, 409-419 (2012).
106. Morihana, T. et al. An inhibitory role for Sema4A in antigen-specific allergic asthma. J. Clin. Immunol. 33, 200-209 (2013).
107. Duran-Struuck, R. et al. A novel role for the semaphorin Sema4D in the induction of allo-responses. Biol. Blood Marrow Transplant. 13, 1294-1303 (2007).
108. Adams, R. H., Lohrum, M., Klostermann, A., Betz, H. & Puschel, A. W. The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing. EMBO J. 16, 6077-6086 (1997). (Pubitemid 27458327)
109. Chen, H., He, Z. & Tessier-Lavigne, M. Axon guidance mechanisms: semaphorins as simultaneous repellents and anti-repellents. Nature Neurosci. 1, 436-439 (1998).
110. Nakamura, F., Tanaka, M., Takahashi, T., Kalb, R. G. & Strittmatter, S. M. Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse. Neuron 21, 1093-1100 (1998). (Pubitemid 29018078)
111. Parker, M. W., Xu, P., Guo, H. F. & Vander Kooi, C. W. Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition. PLoS ONE 7, e49177 (2012).
112. Geretti, E., Shimizu, A., Kurschat, P. & Klagsbrun, M. Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F. J. Biol. Chem. 282, 25698-25707 (2007). (Pubitemid 47372796)
113. Miao, H. Q. et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146, 233-242 (1999).
114. Parker, M. W., Guo, H. F., Li, X., Linkugel, A. D. & Vander Kooi, C. W. Function of members of the neuropilin family as essential pleiotropic cell surface receptors. Biochemistry 51, 9437-9446 (2012).
115. Janssen, B. J. et al. Neuropilins lock secreted semaphorins onto plexins in a ternary signaling complex. Nature Struct. Mol. Biol. 19, 1293-1299 (2012).
116. Siebold, C. & Jones, E. Y. Structural insights into semaphorins and their receptors. Semin. Cell Dev. Biol. 24, 139-145 (2013).
117. Vadasz, Z. et al. The involvement of immune semaphorins and neuropilin-1 in lupus nephritis. Lupus 20, 1466-1473 (2011).
118. Hitomi, Y. et al. Human CD72 splicing isoform responsible for resistance to systemic lupus erythematosus regulates serum immunoglobulin level and is localized in endoplasmic reticulum. BMC Immunol. 13, 72 (2012).
119. Takagawa, S. et al. Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis. BMC Musculoskelet Disord. 14, 40 (2013).
120. Williams, A. et al. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 130, 2554-2565 (2007). (Pubitemid 47511713)
121. Ieda, M. et al. Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nature Med. 13, 604-612 (2007). (Pubitemid 46828481)
122. Catalano, A. et al. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 107, 3321-3329 (2006).
123. Nakagawa, Y. et al. Identification of semaphorin 4B as a negative regulator of basophil-mediated immune responses. J. Immunol. 186, 2881-2888 (2011).
124. Gautier, G. et al. The class 6 semaphorin SEMA6A is induced by interferon-γ and defines an activation status of langerhans cells observed in pathological situations. Am. J. Pathol. 168, 453-465 (2006). (Pubitemid 43271144)
125. Xie, G. et al. Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum. 65, 2457-2468 (2013).
126. Delaire, S. et al. Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J. Immunol. 166, 4348-4354 (2001). (Pubitemid 32233716)
127. Zhu, L. et al. Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1039-1045 (2009).
128. Czopik, A. K., Bynoe, M. S., Palm, N., Raine, C. S. & Medzhitov, R. Semaphorin 7A is a negative regulator of T cell responses. Immunity 24, 591-600 (2006). (Pubitemid 43728148)
129. Walzer, T., Galibert, L., Comeau, M. R. & De Smedt, T. Plexin C1 engagement on mouse dendritic cells by viral semaphorin A39R induces actin cytoskeleton rearrangement and inhibits integrin-mediated adhesion and chemokine-induced migration. J. Immunol. 174, 51-59 (2005). (Pubitemid 40007391)